Implementing Tobacco-Free Policies in Residential Addiction Treatment Settings (1.5 CME)
Discuss the prevalence of nicotine addiction and barriers to treatment among people in addiction treatment settings
Review the data and outcomes of 3 residential treatment centers that transitioned to being tobacco-free
Each participant will be able to develop a Strengths, Weakness, Opportunities and Threats (SWOT) analysis, Stage of Change Analysis
Historically, residential level substance use disorder treatment centers have allowed patients to continue to use tobacco on site and have incorporated only limited treatment for tobacco dependence into their programs. Beliefs associated with this failure to address tobacco dependence have included fears that individuals with tobacco use disorders would lose access to viable treatment because they would refuse to abstain, that treatment center census levels and completion rates could decline or that staff culture would not support such a change. Due to rising concerns about the number of patients and staff who were exposed to second hand smoke, the number of patients who were increasing their tobacco use during treatment, and the number of missed opportunities to treat tobacco dependence, three residential addiction treatment centers transitioned to being tobacco-free facilities between 2013 and 2015. This workshop will present data on how this change in policy had a positive effect on patient admissions and census data and did not reduce access to care for tobacco users. This workshop will then outline key partnerships during this transition, the steps followed during the transition, and lessons learned during this transition. We will conclude with interactive exercises that will allow participants to develop action plans for addressing tobacco use disorders within their own treatment settings.
Contents and Methods:
Powerpoint format for didactic review, presentation of outcomes and outlining key steps in the tobacco-free transition will be used for approximately one-third of the session. Active audience participation during the first third will be encouraged by the use of frequent questions and interaction with participants. The workshop will break into 3 smaller groups to develop individualized plans for the second third of the presentation. The last third of the workshop will be spent in large group discussion regarding potential obstacles to implementation of individualized plans.
Laura F. Martin, M.D. is an Associate Professor of Psychiatry at the University of Colorado School of Medicine. She is a board certified psychiatrist and addiction medicine specialist. She has been recognized as a member of the American College of Psychiatrists, a Fellow of the American Society of Addiction Medicine, and a Distinguished Fellow of the American Psychiatric Association. Her professional roles include serving as the Medical Director of the Center for Dependence, Addiction and Rehabilitation (CeDAR), Program Director of the Addiction Medicine Fellowship at the University of Colorado School of Medicine, and as President of the Colorado Society of Addiction Medicine. She regularly works with individuals with both substance use disorders and other behavioral health disorders to improve their physical and mental health and has published peer reviewed research and clinical reviews regarding this work.
MA, LCAS, CCS, MAC
Brian Coon, MA, LCAS, CCS, MAC is Pavillon's Director of Clinical Programs. His duties include direction of the evaluation and treatment of the medical, legal, and other professionals served at Pavillon, development of organization-wide clinical programing, clinical staff education, internal and external training, outcome evaluation, research and publication. Brian leads pre-admission clinical coordination and approval for admissions to Pavillon's residential programs. Furthermore, Brian is responsible for development and integration of the use of technology within Pavillon's clinical services. He received both his undergraduate degree in psychology and his master's degree in community-clinical psychology from Bradley University in Peoria, Illinois. He began his full-time clinical work during his graduate internship in 1988. Since that time he has worked in addressing co-occurring substance use and mental health disorders in roles ranging from clinician to clinical supervisor and manager of multiple treatment programs. He is a Licensed Clinical Addictions Specialist, Certified Clinical Supervisor, and nationally credentialed as a Master Addiction Counselor. His clinical background is in cognitive-behavioral psychology and evidence-based treatment of co-occurring disorders in various residential and outpatient modalities and levels of care.
Jonathan C. Lee
Jonathan C. Lee, MD, is currently the President-Elect for the Virginia Society of Addiction Medicine (VASAM). He has served as the Secretary/Treasurer for VASAM from 2014 through 2016. He has Co-Chaired the CME program for VASAM meetings in 2015 and 2016. He organized an educational meeting for VASAM members in 2014 to revive chapter activities. He represented VASAM at the ASAM Annual Meeting in 2016 and received our 20th Anniversary plaque. He has collaborated with addiction medicine providers to work with the Virginia Department of Health and the Governor's Task Force and SAMHSA to address the opioid epidemic. Dr. Lee is currently enrolled in an MBA program at the College of William & Mary. He plans to utilize his organizational and management skills to lead VASAM in advocating for access to affordable and effective treatment for patients with addiction.
Since 2010, Dr. Lee has served as Associate Medical Director at the Farley Center in Williamsburg Place to provide addiction treatment for the general adult population and professionals. In 2015, Dr. Lee worked with the various department heads at the Farley Center to transition to a tobacco free program. Dr. Lee is board certified in addiction medicine, internal medicine, and general psychiatry. He completed training in combined internal medicine & psychiatry at Duke University Medical Center. He graduated from the University of Virginia School of Medicine. He completed his bachelors of science with a minor in music at the Massachusetts Institute of Technology.